Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Development of dimeric modulators for anti-apoptotic Bcl-2 proteins.

Wang L, Kong F, Kokoski CL, Andrews DW, Xing C.

Bioorg Med Chem Lett. 2008 Jan 1;18(1):236-40. Epub 2007 Oct 30.

2.

[Progress in small-molecule inhibitors of Bcl-2 family proteins].

Tang Y, Zhang DY, Wu XM.

Yao Xue Xue Bao. 2008 Jul;43(7):669-77. Review. Chinese.

PMID:
18819468
3.

Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer.

Weyhenmeyer B, Murphy AC, Prehn JH, Murphy BM.

Exp Oncol. 2012 Oct;34(3):192-9. Review.

PMID:
23070004
4.

Structural biology of the Bcl-2 family of proteins.

Petros AM, Olejniczak ET, Fesik SW.

Biochim Biophys Acta. 2004 Mar 1;1644(2-3):83-94. Review.

5.

Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria?

Tsujimoto Y.

Genes Cells. 1998 Nov;3(11):697-707. Review.

6.

Mimicking the BH3 domain to kill cancer cells.

Ni Chonghaile T, Letai A.

Oncogene. 2008 Dec;27 Suppl 1:S149-57. doi: 10.1038/onc.2009.52. Review.

7.

Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.

Richardson A, Kaye SB.

Curr Mol Pharmacol. 2008 Nov;1(3):244-54. Review.

PMID:
20021437
8.

Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.

Reed JC, Zha H, Aime-Sempe C, Takayama S, Wang HG.

Adv Exp Med Biol. 1996;406:99-112. Review.

PMID:
8910675
10.

Bcl-2 family proteins as targets for anticancer drug design.

Huang Z.

Oncogene. 2000 Dec 27;19(56):6627-31. Review.

11.

Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion.

Antonsson B.

Cell Tissue Res. 2001 Dec;306(3):347-61. Epub 2001 Oct 30. Review.

PMID:
11735035
12.

Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.

Mohammad R, Giri A, Goustin AS.

Recent Pat Anticancer Drug Discov. 2008 Jan;3(1):20-30. Review.

PMID:
18289121
13.

Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists.

Wang S, Yang D, Lippman ME.

Semin Oncol. 2003 Oct;30(5 Suppl 16):133-42. Review.

PMID:
14613034
14.

Pro-apoptotic activity of BH3-only proteins and BH3 mimetics: from theory to potential cancer therapy.

Hartman ML, Czyz M.

Anticancer Agents Med Chem. 2012 Oct 1;12(8):966-81. Review.

PMID:
22263800
15.

Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.

Chan SL, Yu VC.

Clin Exp Pharmacol Physiol. 2004 Mar;31(3):119-28. Review.

PMID:
15008953
16.

Structural biology of the Bcl-2 family and its mimicry by viral proteins.

Kvansakul M, Hinds MG.

Cell Death Dis. 2013 Nov 7;4:e909. doi: 10.1038/cddis.2013.436. Review.

17.

Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications.

Shacka JJ, Roth KA.

Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):25-39. Review.

PMID:
15723611
18.

A view to a kill: ligands for Bcl-2 family proteins.

Rutledge SE, Chin JW, Schepartz A.

Curr Opin Chem Biol. 2002 Aug;6(4):479-85. Review.

PMID:
12133724
Items per page

Supplemental Content

Write to the Help Desk